Danefred Parodol aSmile ApS

 

Quicksearch
from your own companies




Analyst: XBRLDenmark
 
Loading...

Loading...

Loading...

Loading...

 
Loading...

Bankruptcy Risk 
2019
2020/6
2020
2021/6
2021
2022/6
2022
2023/6
2023
2024/6
Bankruptcy risk for industry  3.6% 3.6% 3.6% 3.6% 3.6%  
Bankruptcy risk  25.4% 19.7% 17.1% 6.2% 5.3%  
Credit score (0-100)  3 6 9 37 41  
Credit rating  B B BB BBB BBB  
Credit limit (kDKK)  -0.0 -0.0 -0.0 -0.0 0.0  

How are these values calculated?
 
View the automatically generated explanation of bankruptcy risk

Income statement (kDKK) 
2019
2020/6
2020
2021/6
2021
2022/6
2022
2023/6
2023
2024/6

Net sales  0 0 0 0 0  
Gross profit  -1.3 -1.2 5.0 34.1 46.9  
EBITDA  -1.3 -1.2 5.0 34.1 46.9  
EBIT  -8.0 -1.2 5.0 34.1 46.9  
Pre-tax profit (PTP)  -15.5 -10.9 -5.0 26.8 37.1  
Net earnings  -15.5 -10.9 -5.0 26.8 37.1  
Pre-tax profit without non-rec. items  -15.5 -10.9 -5.0 26.8 37.1  

 
See the entire income statement

Balance sheet (kDKK) 
2019
2020/6
2020
2021/6
2021
2022/6
2022
2023/6
2023
2024/6

Tangible assets total  0.0 0.0 0.0 0.0 0.0  
Shareholders equity total  -61.4 -72.2 -77.2 -50.4 -13.3  
Interest-bearing liabilities  0.0 87.9 89.4 83.2 68.8  
Balance sheet total (assets)  48.2 39.3 56.0 73.9 74.7  

Net Debt  -29.2 76.6 81.0 53.1 12.7  
 
See the entire balance sheet

Volume 
2019
2020/6
2020
2021/6
2021
2022/6
2022
2023/6
2023
2024/6

Net sales  0 0 0 0 0  
Net sales growth  0.0% 0.0% 0.0% 0.0% 0.0%  
Gross profit  -1.3 -1.2 5.0 34.1 46.9  
Gross profit growth  0.0% 3.7% 0.0% 581.8% 37.8%  
Employees  0 0 0 0 0  
Employee growth %  -100.0% 0.0% 0.0% 0.0% 0.0%  
Employee expenses  0.0 0.0 0.0 0.0 0.0  
Balance sheet total (assets)  48 39 56 74 75  
Balance sheet change%  17.0% -18.6% 42.5% 32.1% 1.0%  
Added value  -1.3 -1.2 5.0 34.1 46.9  
Added value %  0.0% 0.0% 0.0% 0.0% 0.0%  
Investments  -13 0 0 0 0  

Net sales trend  0.0 0.0 0.0 0.0 0.0  
EBIT trend  -3.0 -4.0 1.0 2.0 3.0  

Profitability 
2019
2020/6
2020
2021/6
2021
2022/6
2022
2023/6
2023
2024/6
EBITDA %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT to gross profit (%)  617.2% 100.0% 100.0% 100.0% 100.0%  
Net Earnings %  0.0% 0.0% 0.0% 0.0% 0.0%  
Profit before depreciation and extraordinary items %  0.0% 0.0% 0.0% 0.0% 0.0%  
Pre tax profit less extraordinaries %  0.0% 0.0% 0.0% 0.0% 0.0%  
ROA %  -8.1% -1.1% 4.1% 26.5% 44.2%  
ROI %  -10.7% -1.4% 5.6% 39.5% 61.7%  
ROE %  -34.6% -24.8% -10.4% 41.2% 50.0%  

Solidity 
2019
2020/6
2020
2021/6
2021
2022/6
2022
2023/6
2023
2024/6
Equity ratio %  -56.0% -64.8% -58.0% -40.5% -15.1%  
Relative indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Relative net indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net int. bear. debt to EBITDA, %  2,264.5% -6,169.9% 1,620.9% 155.8% 27.1%  
Gearing %  0.0% -121.8% -115.8% -165.1% -518.9%  
Net interest  0 0 0 0 0  
Financing costs %  0.0% 21.9% 11.2% 8.4% 12.9%  

Liquidity 
2019
2020/6
2020
2021/6
2021
2022/6
2022
2023/6
2023
2024/6
Quick Ratio  1.5 0.5 0.4 0.3 0.7  
Current Ratio  2.1 1.7 1.3 0.6 0.8  
Cash and cash equivalent  29.2 11.4 8.4 30.1 56.1  

Capital use efficiency 
2019
2020/6
2020
2021/6
2021
2022/6
2022
2023/6
2023
2024/6
Trade debtors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Trade creditors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Current assets / Net sales %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net working capital  24.8 15.7 12.2 -50.4 -13.3  
Net working capital %  0.0% 0.0% 0.0% 0.0% 0.0%  

Employee efficiency 
2019
2020/6
2020
2021/6
2021
2022/6
2022
2023/6
2023
2024/6
Net sales / employee  0 0 0 0 0  
Added value / employee  0 0 0 0 0  
Employee expenses / employee  0 0 0 0 0  
EBITDA / employee  0 0 0 0 0  
EBIT / employee  0 0 0 0 0  
Net earnings / employee  0 0 0 0 0